Acute cholecystitis epidemiology and demographics

Jump to navigation Jump to search

Acute cholecystitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute cholecystitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Acute cholecystitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute cholecystitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute cholecystitis epidemiology and demographics

CDC on Acute cholecystitis epidemiology and demographics

Acute cholecystitis epidemiology and demographics in the news

Blogs on Acute cholecystitis epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Acute cholecystitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • The incidence of acute cholecystitis increases with age.

Race

  • Acute cholecystitis usually affects individuals of the North American Indian race. White Americans, Asians, African Americans, and Africans are less likely to develop acute cholecystitis.

Gender

  • Females are more commonly affected by acute cholecystitis than males. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • Acute cholecystitis cases are reported worldwide. America and Europe have high rates of gallbladder stones as compared to Asia and Africa.

Developed Countries

  • Acute cholecystitis accounts for 700,000 cholecystectomies and costs of ∼$6.5 billion annually only in the United States.[1]
    • Acute cholecystitis is prevalent in North America with a racial predisposition to the American Indians.
    • South American countries have slightly more prevalence than the North America.
    • In Europe, Scandinavian countries have the highest prevalence of acute cholecystitis.
    • Italy, Austria, England, Germany, and Poland have a higher prevalence among the rest of Europe.

Developing Countries

References

  1. Shaffer EA (2006). "Gallstone disease: Epidemiology of gallbladder stone disease". Best Pract Res Clin Gastroenterol. 20 (6): 981–96. doi:10.1016/j.bpg.2006.05.004. PMID 17127183.

Template:WH Template:WS